For: | Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, Abe Y, Iijima K, Imatani A, Suzuki K, Hishinuma T, Goto J, Shimosegawa T. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. World J Gastroenterol 2008; 14(15): 2406-2410 [PMID: 18416470 DOI: 10.3748/wjg.14.2406] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i15/2406.htm |
Number | Citing Articles |
1 |
Bhupesh Dewan, Raghuram Chimata. An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition. World Journal of Gastrointestinal Pharmacology and Therapeutics 2010; 1(5): 112-118 doi: 10.4292/wjgpt.v1.i5.112
|
2 |
Michael D. Willard. Small Animal Critical Care Medicine. 2015; : 851 doi: 10.1016/B978-1-4557-0306-7.00161-6
|
3 |
Bhupesh Dewan, Nisha Philipose. Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial. Gastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/640685
|
4 |
Shuichi Ohara, Ken Haruma, Yoshikazu Kinoshita, Motoyasu Kusano. A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis. Journal of Gastroenterology 2010; 45(12): 1219 doi: 10.1007/s00535-010-0283-8
|
5 |
Motoko Nakano, Shizuo Kitano, Masato Nanri, Mamoru Kiniwa. Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism. European Journal of Pharmacology 2011; 658(2-3): 236 doi: 10.1016/j.ejphar.2011.02.007
|
6 |
M. Yadav, V. Trivedi, V. Upadhyay, G. Shah, H. Shah, A. Upadhyay, S. Goswami, P. S. Shrivastav. Sensitive, selective and rapid determination of lafutidine in human plasma by solid phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Analytical Chemistry 2014; 69(5): 448 doi: 10.1134/S1061934814050116
|